"10.1371_journal.pone.0084987","plos one","2014-01-08T00:00:00Z","Guillermo Horga; Emilio Fernández-Egea; Anna Mané; Mireia Font; Kelly C Schatz; Carles Falcon; Francisco Lomeña; Miguel Bernardo; Eduard Parellada","Department of Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center, New York, New York, United States of America; Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain; Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain; Department of Psychiatry, University of Cambridge, Cambridge, and the Cambridgeshire and Peterborough NHS Foundation Trust, Huntingdon, United Kingdom; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Centre Forum, Barcelona, Spain; GIB-UB. CIBER-BBN, Barcelona, Spain; Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain","Conceived and designed the experiments: GH EP FL EF-E MF MB. Performed the experiments: GH AM EF-E MF. Analyzed the data: GH AM KS CF. Wrote the paper: GH.","Dr. Parellada declares having received grant support and lecture fees from Janssen- Cilag and GlaxoSmithKline, and grant support from Lilly. Dr. Lomeña±a declares having received lecture fees from GE Healthcare. Dr. Font declares having received grant support from Maraton TV3 and Janssen-Cilag and travel support from Janssen-Cilag. Dr. Bernardo declares having received grant support from Bristol-Myers Squibb, CIBERSAM, Eli Lilly, FIS-Institute of Health Carlos III, the Government of Catalonia, Janssen-Cilag, Marató TV3, Organon and Pfizer, and declares board membership with and lecture fees from Bristol-Myers Squibb, Eli Lilly, Janssen-Cilag, Mylan and Pfizer. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.",NA,NA,NA,"2014","01","Guillermo Horga","GH",9,TRUE,6,4,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
